Insulin aspart, recombinant Subcutaneous and Sabril
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sabril and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sabril (Vigabatrin Oral Solution)
- Insulin aspart, recombinant Subcutaneous-Sabril (Vigabatrin Tablets)
- Insulin aspart, recombinant Subcutaneous-Sabril Tablets
- Insulin aspart, recombinant Subcutaneous-Sacubitril and valsartan
- Insulin aspart, recombinant Subcutaneous-Safetussin CD
- Insulin aspart, recombinant Subcutaneous-Safetussin DM
- Sabril-Insulin degludec
- Sabril-Insulin Degludec (U-100) Prefilled Pens
- Sabril-Insulin Degludec (U-100) Vials
- Sabril-Insulin Degludec (U-200) Prefilled Pens
- Sabril-Insulin degludec and liraglutide
- Sabril-Insulin degludec and liraglutide Subcutaneous